German Court Rules For Boston Scientific In TAVR Patent Tiff
A German court has issued a preliminary ruling favoring Boston Scientific in its most recent intellectual property dispute with Edwards LifeSciences. The ruling would allow Boston Scientific to block Edwards’ Sapien 3 Ultra from the German market.
You may also be interested in...
Edwards Lifesciences and Boston Scientific announced this week that the firms had resolved an ongoing global patent dispute.
Two closely watched device-world intellectual property cases moved toward a conclusion last week, as Boston Scientific triumphed over Edwards in a TAVR suit and Zimmer was ordered to pay $254m for infringing Stryker’s patent on a surgical-cleaning wand.
Edwards Lifesciences plans a "controlled rollout" of its Sapien 3 Ultra transcatheter heart valve replacement in Europe following the CE mark announced Nov. 16. But a patent dispute with Boston Scientific will prevent Edwards from launching it in Germany.